Analyzing Ramsay Health Care (OTCMKTS:RMYHY) and Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) and Ramsay Health Care (OTCMKTS:RMYHY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Insider & Institutional Ownership

94.9% of Progyny shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Progyny and Ramsay Health Care”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Progyny	$1.27 billion	1.41	$54.34 million	$0.63	32.84
Ramsay Health Care	N/A	N/A	N/A	N/A	N/A

Progyny has higher revenue and earnings than Ramsay Health Care.

Profitability

This table compares Progyny and Ramsay Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Progyny	4.46%	10.71%	7.27%
Ramsay Health Care	N/A	N/A	N/A

Volatility and Risk

Progyny has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Ramsay Health Care has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Progyny and Ramsay Health Care, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Progyny	0	4	8	0	2.67
Ramsay Health Care	1	2	0	0	1.67

Progyny presently has a consensus target price of $29.80, suggesting a potential upside of 44.03%. Given Progyny’s stronger consensus rating and higher probable upside, equities analysts plainly believe Progyny is more favorable than Ramsay Health Care.

Summary

Progyny beats Ramsay Health Care on 10 of the 10 factors compared between the two stocks.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.